
    
      This pilot clinical trial will be a randomized single blinded cross over trial. Each subject
      will undergo three study stages. Subject will be randomized initially to either of the two
      arms; experimental or placebo, and then will be followed up for 3 months for the first stage
      to assess outcomes. In the second stage, both arms transition to a two months, intervention
      free, wash out period. Finally, at the third stage both arms will cross over and subject will
      be followed up for an additional 3 months for outcomes assessment.
    
  